Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 9,774.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 9,774.41% |
Kindly MD, Inc Common Stock (KDLY) | 1,918.55% |
Asset Entities Inc Class B Common Stock (ASST) | 1,536% |
Oncology Institute (TOI) | 883.66% |
Abits (ABTS) | 559.87% |
Nutex Health (NUTX) | 411.18% |
ThredUp (TDUP) | 411.11% |
Oriental Culture Holding (OCG) | 400% |
Dominari (DOMH) | 396.97% |
Regulus Therapeutics (RGLS) | 394.38% |
Sharplink Gaming (SBET) | 366.54% |
Vigil Neuroscience (VIGL) | 363.53% |
VivoPower International (VVPR) | 347.41% |
Curiositystream (CURI) | 334.35% |
Yoshiharu Global (YOSH) | 333.64% |
Global Interactive Technologies (GITS) | 319.09% |
Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | 312.34% |
TMC the metals (TMC) | 311.4% |
Rapid Micro Biosystems (RPID) | 290.11% |
Cantor Equity Partners, Inc Class A Ordinary Shares (CEP) | 275.46% |
Lottery, Inc Common Stock (LTRY) | 275.4% |
Roma Green Finance Limited Ordinary Shares (ROMA) | 258.97% |
Aeva Technologies, Inc Common Stock (AEVA) | 231.89% |
CervoMed (CRVO) | 231.67% |
Lightbridge (LTBR) | 230.77% |
